Vision Science Research 

Alison Abraham, PhD, MS, MHS
Dr. Abraham focuses on vision loss and its impact on aging outcomes with current work in community vision screening for aging adults, particularly those aging with HIV.

Jeffrey Bennett, MD, PhD 
The Bennett laboratory is interested in understanding the pathogenesis of inflammatory disorders of the central nervous system and optic nerve: multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody associated disorder.

Joe Brzezinski, PhD
The Brzezinski Lab studies the genetic mechanisms that control mouse and human retinal development.

Brian Bucca, OD

Anuj Chauhan
Dr. Chauhan's research focuses on developing novel formulations and devices for delivering ophthalmic drugs and mechanistic pharmacokinetic models.

Valeria Canto-Soler, PhD
Development of novel 3D retinal tissues derived from human induced pluripotent stem cells and their use as platforms for developing new treatments for blinding diseases.

Daniel Denman, PhD
The Denman laboratory studies how neurons and neural interactions - within neocortical visual areas and distributed across the brain- generate successful visual perceptions using quantitative psychophysics, in vivo high-density electrophysiology, in vivo imaging, circuit tracing, and computational methods. 

Miguel Flores-Bellver, PhD
The long-term goal of the research carried out by Dr. Flores-Bellver's team is to contribute to a better understanding of the early events involved in early Age-related Macular Degeneration (AMD), including drusen biogenesis.

Lynn Hassman, MD, PhD
The Hassman Lab aims to identify therapeutic targets for uveitis, or ocular inflammatory disease, by combining genomic analysis of patients with in vitro and in vivo models to dissect pathophysiologic mechanisms.

Jayashree Kalpathy-Cramer, PhD
The Devision of Artificial Intelligence in Ophthalmology focuses on developing, evaluating, and deploying AI solutions in healthcare with a focus on ophthalmology.

Todd Kingdom, MD

Jason Kolfenbach, MD

Uday Kompella, PhD, FARVO, FAAPS
The Kompella laboratory focuses on drug and gene delivery research, with a focus on formulations, nanomedicines, and pharmacokinetics.

Melissa Krebs, PhD
Our group is interested in the development of cell-interactive biopolymer systems that will allow the study of cells’ interactions with their microenvironment and that can be used for tissue regeneration and discovery of therapeutics including for glaucoma.

Daniel Labarbera, PhD

Tianjing Li, MD, MHS, PhD
The goal of the Li Lab's research is to develop, evaluate, and disseminate methods for comparing healthcare interventions and to provide trustworthy evidence for decision making. She directs the NEI-funded Cochrane Eyes and Vision US Project.

Suhsun (Alison) Liu, MD, PhD
Dr. Liu is interested in leveraging electronic health record data to inform clinical practice and policies with a specific focus on dry eye. 

Anne Lynch, MD, MSPH
Dr. Lynch investigates the role of systemic inflammatory biomarkers in age-related macular degeneration along with the links between maternal complications of pregnancy and the development of retinopathy of prematurity.

 Steve McNamara, OD

Ram Nagaraj, PhD
Dr. Nagaraj's laboratory investigates mechanisms and develops therapeutic interventions for secondary cataracts, and neurovascular degeneration in glaucoma and diabetes.

Maria Nagel, PhD

Mi-Hyun Nam, PhD
Dr. Nam's research primarily focuses on developing neuroprotective therapeutics for retinal ganglion cells (RCG's) in animal models of eye diseases, with a particular emphasis on glaucoma and traumatic optic neuropathies.

Daewon Park, PhD

 Jennifer Patnaik, PhD
Dr. Patnaik focuses on age-related mascular degeneration, retinopathy of prematurity, cataract and glaucoma surgeries, and other ophthalmic diseases. She is especially interested in assessing disparities in ocular disease within vulnerable populations.

 Victoria Pelak, MD
Dr. Pelak’s research focuses on processing of vision in the brain in association with aging and with neurodegenerative diseases such as Alzheimer’s disease.

 Mark Petrash, PhD
Dr. Petrash is a retired professor who continues collaborations to study cataract mechanisms and novel therapies to reverse lens opacification and prevent post-surgical development of capsule opacification.

Alon Poleg-Polsky, MD, PhD
Dr. Poleg-Polsky uses electrophysiology, 2-photon imaging, and machine learning to understand visual computations in the rodent retina.

Riaz Qureshi, MD
Dr. Qureshi is interested in the methods used to investigate harms of interventions at different levels of evidence: from adverse events collected and reported in clinical trials to the synthesis of harms in systematic reviews.

Praveer Singh, PhD

 Natalia Vergara, PhD
The Vergara Lab uses stem cell technologies to model developmental abnormalities and degenerative diseases of the human retina, with the goal of advancing novel treatments to prevent vision loss or blindness.

Brandie Wagner, PhD

 Kia Washington, MD
Dr. Washington's research interests include a comprehensive approach to research in whole eye transplantation and improving peripheral and central nerve regeneration after injury and in the setting of vascularized composite allotransplantation.

 Trevor Williams, PhD

Chris Yakacki, PhD